Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ACARBOSE FOR PEAK IDENTIFICATION CRS (20 MG)

ACARBOSE FOR PEAK IDENTIFICATION CRS (20 MG)

56180-94-0

DISCOVER
METHANOL - REFERENCE SPECTRUM(N/A)

METHANOL - REFERENCE SPECTRUM(N/A)

NA

DISCOVER
TROSPIUM CHLORIDE CRS (15 MG)

TROSPIUM CHLORIDE CRS (15 MG)

10405-02-4

DISCOVER
TROSPIUM IMPURITY C CRS (5 MG)

TROSPIUM IMPURITY C CRS (5 MG)

3464-71-9

DISCOVER
TROSPIUM IMPURITY B CRS (20 MG)

TROSPIUM IMPURITY B CRS (20 MG)

16444-19-2

DISCOVER
TROSPIUM IMPURITY A CRS (20 MG)

TROSPIUM IMPURITY A CRS (20 MG)

76-93-7

DISCOVER
AMMONIUM GLYCYRRHIZATE  CRS (70 MG)

AMMONIUM GLYCYRRHIZATE CRS (70 MG)

53956-04-0

DISCOVER
BOLDINE CRS (30 MG)

BOLDINE CRS (30 MG)

476-70-0

DISCOVER
CAPTOPRIL IMPURITY E CRS (15 MG)

CAPTOPRIL IMPURITY E CRS (15 MG)

NA

DISCOVER
CHLORPHENAMINE IMPURITY A CRS(0.01 MG)

CHLORPHENAMINE IMPURITY A CRS(0.01 MG)

NA

DISCOVER
CHLORPHENAMINE IMPURITY C CRS(15 MG)

CHLORPHENAMINE IMPURITY C CRS(15 MG)

NA

DISCOVER
COUMARIN CRS (160 MG)

COUMARIN CRS (160 MG)

91-64-5

DISCOVER